1.57 USD
▲+0.01+0.64%
盘后 1.59 +1.27%
2026-09-15
市值
$1.20B
市盈率
—
EPS
-0.09
股息率
—
52 周区间
0.98 – 1.73
成交量
1.42M
Beta
1.50
目标价
4.38
52W 低 0.9852W 高 1.73
价格走势
公司简介
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune syst...